搜尋結果
Chinese Academy of Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute of Medical Biology, Chinese Academy of Medical Sciences [].
In 2020, the first COVID‑19 vaccines were developed and made available to the public through emergency authorizations and conditional approvals. Initially, most COVID‑19 vaccines were two-dose vaccines, with the sole exception being the single-dose .
The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. The vaccine is used to reduce morbidity and mortality from COVID-19.
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech , Oxford–AstraZeneca , Sinopharm BIBP , Moderna ...
- Administration
- Vaccines
- See Also
- References
In June 2020, the Sinopharm BIBP vaccine (BBIBP-CorV) was authorized for emergency usein China. On July 22, Chinese authorities started the emergency use of COVID-19 vaccines. On December 15, 2020, the COVID-19 vaccination for people under high risk started in China. On December 19, 2020, the National Health Commission(NHC) said that there has been...
As of November 21, 2022, seven vaccines have been approved in mainland China through conditional marketing authorization or emergency use authorization. In 2021 Nature reported that "studies have questioned the length of protection" that domestic vaccines such as CoronaVac and Sinopharm offer, especially when compared to mRNA vaccines. A 2022 meta-...
Daily reports on COVID-19 vaccinationNews and ArticlesThe Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). [29] Medical uses. The Novavax COVID‑19 vaccine is indicated for active immunization to prevent COVID‑19 caused by SARS-CoV-2. [4]
The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).
